CymaBay Therapeutics, Inc.

符号: CBAY

NASDAQ

32.48

USD

今天的市场价格

-32.9591
市盈率
0.0000
PEG比率
3.73B
MRK市值
0.00%
DIV收益率

CymaBay Therapeutics, Inc. (CBAY) 财务报表

Q: 什么是 CymaBay Therapeutics, Inc. (CBAY) 总资产是多少？

CymaBay Therapeutics, Inc. (CBAY) 总资产为 .

Download

年度季度

线性对数

在图表中，您可以看到的动态默认数字 CymaBay Therapeutics, Inc. (CBAY). 的默认数据。公司收入显示 3.677 M 的平均值，即 -0.167 % 增长率。整个期间的平均毛利润为 3.384 M，即 3.491 %. 平均毛利率为 0.248 %. 公司去年的净收入增长率为 -0.114 %，等于 -0.408 % % 整个公司历史的平均增长率.,

年度季度

10Y 20Y 30Y 40Y

资产负债表

深入分析 CymaBay Therapeutics, Inc. 的财务轨迹，我们可以看到其平均资产增长率。有趣的是，这一增长率为，反映了公司的高点和低点。与季度相比，这一数字调整为0. 回顾过去一年，总资产变化为 2.064. 在流动资产领域，CBAY 的报告货币为403.802. 这些资产中的很大一部分，即 394.255 是现金和短期投资。与去年的数据相比，该部分的变化率为1.910%. 公司的长期投资虽然不是其重点，但以报告货币计算的22.36（如果有的话）为22.36。这表明与上一报告期相比，0.000% 的差异反映了公司的战略转变. 公司的债务概况显示，以报告货币计算的长期债务总额为 99.172. 这一数字表明，0.259% 的年同比变化. 股东权益总额所体现的股东价值是以报告货币计算的 292.256. 这方面的年同比变化率为 7.084%. 深入了解公司财务信息后，会发现更多细节。应收账款净额的估值为0，存货估值为 0，商誉估值为 0（如有. 无形资产总额（如果有）按 0 估值.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
balance-sheet.row.cash-and-short-term-investments	1283.24	394.3	135.5	186.5	146.3	190.9	178.7	97.2	17	41.5	34.8	31.2	7.7
balance-sheet.row.short-term-investments	708.35	187.7	115.2	60.7	118.1	166.1	129.7	74.2	6.5	33.8	23.2	6.8	0
balance-sheet.row.net-receivables	0	0	0	0	0.3	0.7	0	5	0	0.2	0.3	0.2	0.1
balance-sheet.row.inventory	0	0	0	0	0	0	0	1.2	0	0	2	0.4	0
balance-sheet.row.other-current-assets	35.01	9.5	2.6	4.6	5	11.3	0.3	0.1	0.2	1.1	0.1	0.5	0.1
balance-sheet.row.total-current-assets	1318.25	403.8	138.1	191.1	151.6	202.9	181.6	103.5	18.5	42.8	37.2	32.2	8
balance-sheet.row.property-plant-equipment-net	7.83	5.7	0.9	1.4	2	2.6	2.9	0.1	0.1	0.1	0.1	0	0.1
balance-sheet.row.goodwill	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.goodwill-and-intangible-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-investments	22.36	22.4	0	8.1	0	0	0	0	0	0	0	0	0
balance-sheet.row.tax-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.other-non-current-assets	9.26	2.8	2.9	1.7	0.2	0.2	2.3	0.6	0.8	0.2	0.2	0.3	0
balance-sheet.row.total-non-current-assets	39.45	30.9	3.8	11.2	2.2	2.8	5.2	0.7	0.8	0.3	0.2	0.3	0.1
balance-sheet.row.other-assets	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-assets	1357.7	434.7	141.9	202.3	153.8	205.7	186.7	104.2	19.4	43.1	37.5	32.5	8.1
balance-sheet.row.account-payables	12.78	3.8	1.1	2.7	0.2	2.5	2	1.3	0.9	1	2.1	0.7	0.7
balance-sheet.row.short-term-debt	11.12	10	0.7	0.6	0.5	0.4	0	3.1	2.7	0.5	1.4	0	13.7
balance-sheet.row.tax-payables	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.long-term-debt-total	397.14	99.2	90.3	51	1.3	1.7	0	3	6.1	8.8	3.2	4.4	0
Deferred Revenue Non Current	3.3	1.1	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.deferred-tax-liabilities-non-current	-203.34	-	-	-	-	-	-	-	-	-	-	-	-
balance-sheet.row.other-current-liab	58.31	21.3	13.7	15.1	9.1	14.7	12.4	6.1	1.1	1.2	13.6	6.9	3.6
balance-sheet.row.total-non-current-liabilities	405.76	105.6	90.3	51	1.3	1.7	1.9	3	6.1	8.8	3.2	4.4	318.7
balance-sheet.row.other-liabilities	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.capital-lease-obligations	6.43	5.3	0.7	1.3	1.7	2.1	0	0	0	0	0	0	0
balance-sheet.row.total-liab	526.66	142.4	105.7	69.4	11.1	19.4	16.3	19.3	15.4	15	23.6	13.9	336.7
balance-sheet.row.preferred-stock	0	0	0	0	0	0	0	0	0	0	0	32.5	0
balance-sheet.row.common-stock	0.06	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.retained-earnings	-3718.63	-978.2	-872.9	-766.9	-676.9	-625.9	-523.1	-450.5	-423	-396.3	-380.8	-348.8	-329.5
balance-sheet.row.accumulated-other-comprehensive-income-loss	-0.11	0.1	-0.3	0	0	0.1	-0.1	0	0	0	0	0	0
balance-sheet.row.other-total-stockholders-equity	4549.72	1270.3	909.3	899.8	819.5	812.1	693.5	535.5	426.9	424.4	394.6	334.9	0.9
balance-sheet.row.total-stockholders-equity	831.04	292.3	36.2	132.9	142.7	186.3	170.4	84.9	3.9	28.1	13.8	18.6	-328.6
balance-sheet.row.total-liabilities-and-stockholders-equity	1357.7	434.7	141.9	202.3	153.8	205.7	186.7	104.2	19.4	43.1	37.5	32.5	8.1
balance-sheet.row.minority-interest	0	0	0	0	0	0	0	0	0	0	0	0	0
balance-sheet.row.total-equity	831.04	292.3	36.2	132.9	142.7	186.3	170.4	-	-	-	-	-	-
balance-sheet.row.total-liabilities-and-total-equity	1357.7	-	-	-	-	-	-	-	-	-	-	-	-
Total Investments	730.71	210.1	115.2	68.8	118.1	166.1	129.7	74.2	6.5	33.8	23.2	6.8	0
balance-sheet.row.total-debt	413.58	114.5	90.9	51.6	1.7	2.1	0	6.1	8.8	9.3	4.5	4.4	13.7
balance-sheet.row.net-debt	-161.31	-92	70.6	-74.2	-26.4	-22.7	-49	-17	-1.7	1.6	-7.1	-20	6

现金流量表

在 CymaBay Therapeutics, Inc. 的财务状况中，自由现金流在过去一段时间内发生了显著变化，呈现出 0.134 的转变。该公司最近通过发行 345.77 扩大了股本，与上一年相比出现了37.500 的差异. 有趣的是，公司的部分股票，特别是 0，是由公司自己回购的。这一举动导致0.000 比上一年有所变化。同时，以报告货币计算，公司的应付账款目前为 2.73. 公司的投资活动产生了现金使用净额，按报告货币计算达到-86569000.000. 与上一年相比， 0.883 发生了变化. 在同一时期，公司记录了 0.68, 7.86 和 0，这对于了解公司的投资和还款策略具有重要意义. 公司的融资活动导致使用的现金净额为0.000，同比差异为0.000. 此外，公司还将0 用于向股东分红。与此同时，该公司还采取了其他财务措施，即 335.14，这也对其在此期间的现金流产生了重大影响. 这些组成部分合在一起，全面反映了公司的财务状况和现金流管理的战略方针。

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
cash-flows.row.net-income	-105.37	-105.4	-106	-90	-51	-102.8	-72.5	-27.6	-26.7	-15.5	-31.9	-10.1	-11.3
cash-flows.row.depreciation-and-amortization	0.68	0.7	0.7	0.7	0.6	0.6	0.1	0	0	0	0	0.1	0.1
cash-flows.row.deferred-income-tax	-7.77	-2.7	0	0.6	0	-3.1	1.8	5.6	0.1	-10.6	7.7	-0.1	0
cash-flows.row.stock-based-compensation	15.23	15.2	9.5	10	7.3	10.5	7	4.9	2.5	2.5	1.3	0.9	0.1
cash-flows.row.change-in-working-capital	5.63	5.6	-2.3	6.4	-1.6	-3.9	8.9	-3	0.3	0.1	1.6	0.7	-0.3
cash-flows.row.account-receivables	0	0	0	0	0	0	0	-5	0	0.2	-0.1	0	0
cash-flows.row.inventory	0	0	0	0	0	0	0	1.4	0	0.9	0.3	0.7	0.7
cash-flows.row.account-payables	2.73	2.7	-1.4	2.3	-2.3	0.5	0.7	0.4	-0.1	-1.1	1.4	0	-1
cash-flows.row.other-working-capital	2.9	2.9	-0.9	4	0.7	-4.4	8.2	0.1	0.4	0	0	0	-0.1
cash-flows.row.other-non-cash-items	19.06	14	14	2.9	-0.1	0.9	-0.1	0.4	0.5	0.2	0.2	0.1	0.1
cash-flows.row.net-cash-provided-by-operating-activities	-72.53	0	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.investments-in-property-plant-an-equipment	-0.45	-0.4	-0.1	-0.1	0	-0.3	-0.5	0	0	0	-0.1	0	0
cash-flows.row.acquisitions-net	-2.11	-7.9	-0.9	0.6	-0.1	-2.2	-1.9	-0.2	0	0	0	0	0
cash-flows.row.purchases-of-investments	-305.67	-305.7	-175	-78.1	-176.3	-290.9	-276.4	-98.4	-22.9	-42.8	-27.3	-6.9	-2.9
cash-flows.row.sales-maturities-of-investments	219.55	219.6	129.1	126.8	224.3	256.9	222.8	30.9	50.1	31.7	10.5	0	13.9
cash-flows.row.other-investing-activites	2.11	7.9	0.9	-0.6	0.1	2.2	1.9	0.2	0	0	0	0.7	0
cash-flows.row.net-cash-used-for-investing-activites	-86.57	-86.6	-46	48.6	48	-34.3	-54.1	-67.5	27.1	-11.1	-16.9	-6.2	11
cash-flows.row.debt-repayment	0	0	-25	-47.7	0	0	-6.5	-3.1	-1	-4.8	-0.2	0	0
cash-flows.row.common-stock-issued	339.36	345.8	-0.5	70.5	0.1	107.7	135.5	100.4	0	25.4	25.4	26.5	0
cash-flows.row.common-stock-repurchased	0	0	-0.5	0	0	0	0	0	0	0	0	0	0
cash-flows.row.dividends-paid	0	0	-25	0	0	0	0	0	0	0	0	0	0
cash-flows.row.other-financing-activites	7.46	335.1	75.5	95.7	0.1	0.4	6	2.4	0	9.9	0.1	4.9	0
cash-flows.row.net-cash-used-provided-by-financing-activities	345.77	345.8	24.6	118.5	0.1	108.1	135	99.7	-1	30.5	25.2	31.4	0
cash-flows.row.effect-of-forex-changes-on-cash	26.59	-0.4	0	0	0	0	0	0	0	0	0	0	0
cash-flows.row.net-change-in-cash	186.24	186.2	-105.5	97.6	3.3	-24.1	25.9	12.6	2.8	-3.9	-12.8	16.7	-0.3
cash-flows.row.cash-at-end-of-period	574.89	206.5	20.3	125.8	28.2	24.9	49	23.1	10.5	7.7	11.6	24.4	7.7
cash-flows.row.cash-at-beginning-of-period	388.64	20.3	125.8	28.2	24.9	49	23.1	10.5	7.7	11.6	24.4	7.7	8
cash-flows.row.operating-cash-flow	-72.53	-72.5	-84.1	-69.4	-44.7	-97.9	-54.9	-19.6	-23.4	-23.3	-21.1	-8.5	-11.3
cash-flows.row.capital-expenditure	-0.45	-0.4	-0.1	-0.1	0	-0.3	-0.5	0	0	0	-0.1	0	0
cash-flows.row.free-cash-flow	-72.98	-73	-84.2	-69.5	-44.7	-98.2	-55.5	-19.7	-23.4	-23.3	-21.2	-8.5	-11.3

利润表行

CymaBay Therapeutics, Inc. 的收入与上期相比变化了 0.000%。据报告, CBAY 的毛利润为 30.39。该公司的营业费用为 132.07，与上年相比变化了 41.843%. 折旧和摊销费用为 0.68，与上一会计期间相比变化了 -0.662%. 营业费用报告为 132.07，显示41.843% 的同比变化。销售和营销费用为 0, 其中 0.000% 与上年相比发生了变化。基于近期数据的EBITDA为 0，同比增长-0.092%. 营业收入为 -101.68，与上年相比变化了0.092%. 净利润的变化率为 -0.114%。去年的净收入为-105.37.

common:word.in-mln USD Growth	TTM	2022	2020	2018	2016	2014	2012
income-statement-row.row.total-revenue	31.07	31.1	0	0	0	0	0	10	0	0	0	0	3
income-statement-row.row.cost-of-revenue	0.68	0.7	0.7	0.7	0.6	0.8	0	0	0	0	0	0	0
income-statement-row.row.gross-profit	30.39	30.4	-0.7	-0.7	-0.6	-0.8	0	10	0	0	0	0	3
income-statement-row.row.gross-profit-ratio	0	0	0	0	0	0	0	0	0	0	0	0	0
income-statement-row.row.research-development	80.74	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-general-administrative	51.95	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-expenses	1.76	1.8	0	0	0	5.1	-3.3	-5.8	0.1	11.1	-7.2	0.1	0
income-statement-row.row.operating-expenses	132.7	132.1	93.1	87.6	53.3	103.1	72.5	31.3	25.6	25.9	24	9.4	13.5
income-statement-row.row.cost-and-expenses	132.75	132.8	93.1	87.6	53.3	103.1	72.5	31.3	25.6	25.9	24	9.4	13.5
income-statement-row.row.interest-income	13.49	13.5	2	0.2	1.6	5.3	4	0.6	0.2	0.2	0.1	0	0
income-statement-row.row.interest-expense	9.26	18.9	14.9	2.6	0	0	0.3	1.1	1.3	0.9	0.8	0.8	0.8
income-statement-row.row.selling-and-marketing-expenses	0	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.total-other-income-expensenet	-1.7	-3.7	-12.9	-2.4	1.6	5.3	-3.7	-5.8	0.1	11.1	-7.2	0.1	0
income-statement-row.row.ebitda-ratio-caps	0	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.other-operating-expenses	1.76	1.8	0	0	0	5.1	-3.3	-5.8	0.1	11.1	-7.2	0.1	0
income-statement-row.row.total-operating-expenses	-1.7	-3.7	-12.9	-2.4	1.6	5.3	-3.7	-5.8	0.1	11.1	-7.2	0.1	0
income-statement-row.row.interest-expense	9.26	18.9	14.9	2.6	0	0	0.3	1.1	1.3	0.9	0.8	0.8	0.8
income-statement-row.row.depreciation-and-amortization	3.18	0.7	2	0.9	-0.8	10.4	0.1	0	0	0	0	0.1	0.1
income-statement-row.row.ebitda-caps	-94.8	-	-	-	-	-	-	-	-	-	-	-	-
income-statement-row.row.operating-income	-101.68	-101.7	-93.1	-87.6	-52.6	-108.2	-72.5	-21.3	-25.6	-25.9	-24	-9.4	-10.4
income-statement-row.row.income-before-tax	-105.37	-105.4	-106	-90	-51	-102.8	-72.5	-27.6	-26.7	-15.5	-31.9	-10.1	-11.3
income-statement-row.row.income-tax-expense	11.99	0	12.9	2.6	-2.3	-0.6	0.3	-4.7	1.4	12	-6.5	1	0.8
income-statement-row.row.net-income	-111.68	-105.4	-118.9	-92.6	-48.7	-102.2	-72.5	-27.6	-26.7	-15.5	-31.9	-10.1	-11.3